Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 7, 2013, Pages 806-813

  Ansari, Mohammad A ^a   Irshad, Mohammad ^a   Agarwal, Sanjay Kumar ^a   Chosdol, Kunzang ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

CORE; expression; genotype; hepatitis C virus; immunoassay

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ARTICLE; BLOOD SAMPLING; CORE GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE SEQUENCE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; PHYLOGENY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIRUS GENE; VIRUS GENOME; WESTERN BLOTTING;

ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY COMPLEX; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CLONING, MOLECULAR; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; IMMUNOASSAY; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RECOMBINANT PROTEINS; RNA, VIRAL; VIRAL CORE PROTEINS;

EID: 84879975683     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32835eb9b9     Document Type: Article

References (34)

1. Irshad M, Acharya SK, Joshi YK. Prevalence of hepatitis Cvirus antibodies in the general population & in selected groups of patients in Delhi. Indian J Med Res 1995; 102:162-164.
2. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a c DNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-362.
3. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13:2436-2441.
4. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999; 6:35-47.
5. Alter MJ, Margolis SH, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community acquired hepatitis C in United States. N Engl J Med 1992; 327:1899-1905.
6. Chakravarti A, Verma V, Jain M, Kar P. Characteristic of dual infection of hepatitis B and Cviruses among patients with chronic liver disease: a study from tertiary care hospital. Trop Gastroenterol 2005; 26:183-187.
7. Fabrizi F, Takkouche B, Lunghi G, Dixit V, Messa P, Martin P. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat 2007; 14:697-703.
8. Huskey J, Wiseman AC Chronic viral hepatitis in kidney transplantation. Nat Rev Nephrol 2011; 7:156-165.
9. Perico N, Cattaneo D, Bikbov B, Remuzzi G. Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 2009; 4:207-220.
10. Romero E, Galindo P, Bravo JA, Osorio JM, Pérez A, Baca Y, et al. Hepatitis C virus infection after renal transplantation. Transplant Proc 2008; 40:2933-2935.
11. James MC, Kumar V, Abbas AK, Fausto N. The Liver and Biliary Tract. In: Robbins C, editor. In pathologic basis ofdisease. 7 ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2005; Vol. 894:p. 19106.
12. Rho J, Ryu JS, Hur W, Kim CW, Jang JW, Bae SH, et al. Hepatitis C virus (HCV) genotyping by annealing reverse transcription-PCR products with genotype-specific capture probes. J Microbiol 2008; 46:81-87.
13. Lindenbach BD, Rice CM. Flaviviridae. The viruses andtheirreplication. Philadelphia, PA: Lippincott Williams & Wikins; 2001. pp. 991-1041.
14. De Francesco R. Molecularvirology of the hepatitis Cvirus. J Hepatol 1999; 31:47-53.
15. Tellinghuisen TL, Rice CM. Interaction between hepatitis C virus proteins and host cell factors. Curr Opin Microbiol 2002; 5:419-427.
16. Pawlotsky JM. Hepatitis C Virus genetic variability: pathogenic and clinical implications. Clin Liver Dis 2003; 7:45-66.
17. Pukhrambam PD, Singh NB, Singh LH, Devi KS. Pattern of hepatitis C virus genotypes in HIV infected patients in RIMS, Hospital, Imphal, Manipur. J Commun Dis 2007; 39:21-24.
18. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH. Hepatitis Cvirus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med 1996; 125:634-639.
19. Schroter M, Feucht HH, Schafer P, Zöllner B, Laufs R. Serological determination of hepatitis C virus subtypes 1a, 1b, 2a, 2b, 3a and 4a by a recombinant immunoblot assay. J Clin Microbiol 1999; 37:2576-2580.
20. Cook L, Sullivan K, Krantz EM, Bagabag A, Jerome KR. Multiplex real-time reverse transcription-PCR assay for determination of hepatitis C virus genotypes. J Clin Microbiol 2006; 44:4149-4156.
21. Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky J-M. Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice. PLo S One 2009; 4:e 8209.
22. Alfaresi MS, Elkoush AA. Determination of hepatitis C virus genotypes by melting-curve analysis of quantitative polymerase chain reaction products. Indian J Med Microbiol 2007; 25:249-252.
23. Le Pogam S, Dubois F, Christen R, Raby C, Cavicchini A, Goudeau A. Comparison of DNA enzyme immunoassay and line probe assays (Inno-Li PA HCV I and II) for hepatitis C virus genotyping. J Clin Microbiol 1998; 36:1461-1463.
24. Ohno O, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCVgenotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997; 35:201-207.
25. Okamoto H, Kojima M, Okada S, Yoshizawa H, Iizuka H, Tanaka T, et al. Genetic drift of hepatitis Cvirus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 1992; 190:894-899.
26. Ross RS, Viazov S, Roggendorf M. Genotyping of hepatitis C virus isolates by a new line probe assay using sequence information from both the 5' untranslated and the core regions. J Virol Methods 2007; 143:153-160.
27. Ansari Mohammad Ahmad, Lingaiah Raghavendra, Irshad Mohammad. HCV-core region: its significance in HCV-genotyping and type dependent genomic expression. Macedonian J Med Sci 2012; 5:30-39.
28. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
29. Zein N. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 2000; 13:223-235.
30. Furusyo N, Hayashi J, Kanamoto-Tanaka Y, Ariyama I, Etoh Y, Shigematsu M, Kashiwagi S. Liver damage in hemodialysis patients with hepatitis C virus viremia: a prospective 10-year study. Dig Dis Sci 2000; 45:2221-2228.
31. Yousaf MZ, Idrees M, Saleem Z, Rehman IU, Ali M. Expression of core antigen of HCV genotype 3a and its evaluation as screening agent for HCV infection in Pakistan. Virol J 2011; 8:364.
32. Leon P, Lopez JA, Elola C, Quan S, Echevarria JM. Typing of hepatitis C virus antibody with specific peptides in seropositive blood donors and comparison with genotyping of viral RNA. Vox Sang 1997; 72: 71-75.
33. Kazemi B, Bandehpour M, Seyed N, Roozbehi M, Mosaff N. Cloning and expression of hepatitis Cvirus core protein in p Gemex-1 expression vector. Arch Iran Med 2008; 11:173-178.
34. Sillanpää M, Melén K, Porkka P, Fagerlund R, Nevalainen K, Lappalainen M, Julkunen I. Hepatitis Cvirus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection. Virol J 2009; 6:84.